Moderna has announced that initial data from its Phase II study shows that a single 50µg dose of mRNA-1273 or mRNA-1273.351 given as a booster to previously vaccinated individuals increased neutralizing antibody titre responses against SARS-CoV-2 and two variants of concern, B.1.351 (first identified in South Africa) and P.1 (first identified in Brazil).
Standard Bariatrics® announced today that its novel Titan SGS™ stapling technology, designed specifically for bariatric sleeve surgery, has been cleared by the US Food and Drug Administration (FDA).
Orange Photonics is pleased to announce that the LightLab 3 Cannabis Analyzer now reports Delta-8 THC (D8-THC), an increasingly popular cannabinoid found in hemp-derived cannabis products.
In a major breakthrough for testing COVID-19 immunity, JOYSBIO, a Chinese medical device manufacturer, just announced the completion of a clinical study in Italy, showing their COVID-19 neutralizing antibody rapid test kit is 98.05% effective in detecting neutralizing antibodies in subjects given the Pfizer-BioNTech vaccine.
The Specialty Hospital, Amman, Jordan, today announced it is the first hospital within the MENA region to adopt the innovative geko™ device for Venous Thromboembolism (VTE) prevention in high-risk vascular patients, unable to be prescribed standard of care.
Judged out of Hamburg in Germany, iF awards recognise products from around the world that exhibit superior innovation and exemplary design. Today, ACG announced that it has received one such award for 'Karton X', a packaging machine in its new generation series.
Aegis Life, Inc. announced today that the first participants have been dosed in a Phase 1/2 clinical trial with parent company Entos Pharmaceuticals’ (Entos) Covigenix VAX-001, a novel DNA vaccine to stimulate immunity against SARS-CoV-2.
LGC Maine Standards¹ announces a product update for VALIDATE® Diabetes which meets the linearity and calibration verification needs of clinical laboratories running the Roche cobas® platform.
Four months after raising its seed round from Hoxton Ventures and dRX Capital, a venture arm of Novartis Pharma AG, Peptone, the molecular computational physics company focused on protein drug discovery and engineering tools.
In recent weeks, 3B Medical announced the release of its new portable and compact UVC sanitizer, the Lumin Wand, which uses ultraviolet germicidal irradiation (UVGI) to kill 99.9 percent of harmful germs and bacteria in just seconds.